Komori
Other Disclosures4890Tsubota Laboratory IncorporatedPharmaceuticals

Received the Heinrich Meibom Distinguished Lecture Award

Representative Director and President Tsubota Kazuo (坪田 一男) spoke at DESA Conference 2026 and received the Heinrich Meibom Distinguished Lecture Award.

Worth reading
49Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Announced details

TLM-001
Applicable field (uses covered by this announcement)

Dry eye, ocular surface diseases, meibomian gland dysfunction (MGD)

Relationship between the counterparty and the company
Tsubota Laboratory Incorporated4890
Relationship with the Company

The company's Representative Director and President spoke at DESA Conference 2026 and received an award from the organization. Detailed information on capital, personnel and business relationships is Not disclosed.

CounterpartyDESA(Dry Eye Society of the Americas)

A nonprofit organization established in the United States in 2025 to promote awareness, education, collaboration among researchers and healthcare professionals, and patient-centered care relating to dry eye disease. Detailed information on its location, representative and capital is Not disclosed.

Award/certification name

Heinrich Meibom Distinguished Lecture Award

Awarding / certifying body

DESA(Dry Eye Society of the Americas)Conference 2026

Location (as indicated in this announcement)

New York, United States (venue of DESA Conference 2026)

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Source (materials cited by the company)

Official DESA (Dry Eye Society of the Americas) URL (https://dryeyesocietyoftheamericas.org/)

Announced details
ItemDetails
Names of Products / Services CoveredTLM-001
CounterpartyDESA(Dry Eye Society of the Americas)
Counterparty overviewA nonprofit organization established in the United States in 2025 to promote awareness, education, collaboration among researchers and healthcare professionals, and patient-centered care relating to dry eye disease. Detailed information on its location, representative and capital is Not disclosed.
Relationship with the CompanyThe company's Representative Director and President spoke at DESA Conference 2026 and received an award from the organization. Detailed information on capital, personnel and business relationships is Not disclosed.
Applicable areaDry eye, ocular surface diseases, meibomian gland dysfunction (MGD)
Award/certification nameHeinrich Meibom Distinguished Lecture Award
Awarding / certifying bodyDESA(Dry Eye Society of the Americas)Conference 2026
LocationNew York, United States (venue of DESA Conference 2026)
SourceOfficial DESA (Dry Eye Society of the Americas) URL (https://dryeyesocietyoftheamericas.org/)
Items this document does not state (9)
Contract ValueOffering priceContract DateLaunch dateRegistration number and expiry dateLocation scaleQuantitative EffectsUsage historyImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because he has conducted basic and clinical research into ocular surface diseases, including dry eye, for many years.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Received the Heinrich Meibom Distinguished Lecture Award | Tsubota Laboratory Incorporated (4890) timely disclosure | Komori